Healthcare
Johnson & Johnson JNJ
$266.30
+2.49 (0.94%) today
JNJ
Johnson & Johnson—
Today
— · USD
Loading prices…
Revenue by Product & Services
Loading…
Revenue Breakdown
—
Past 5 years
Loading prices…
Profit & Cash Flow
Show
RevenueOperating IncomeFree Cash FlowExpenses
Each bar stacks the items you turn on; hover a bar for each amount. Expenses = revenue minus operating income. Figures from SEC filings.
Tip: click any year on a chart to see all of its numbers.
Market Cap
$646.9B+0%
Revenue
$94.2B+23%
Break down by
Loading revenue breakdown…
Operating Income
—
Not reported for this period
Net Income
$26.8B+1962%
Free Cash Flow
$19.7B+11%
Revenue to Market Cap
—
Not reported for this period
P/E Ratio
—
Not reported for this period
Operating Margin
—
Not reported for this period
Debt to Equity
0.51x+0%
Shares Outstanding
2.43B+254%
Dividend Yield
—
Not reported for this period
Latest JNJ news
- Your Pension Still Pays the Same $3,100 It Did the Day You Retired. These 3 ETFs Give You the Raise It Never Will10/26/2026
- What Do Johnson & Johnson (JNJ) Cancer Trial Wins Mean For Its Stock?10/26/2026
- ORIC Pharmaceuticals Sinks 22% as J&J Presents Rival Prostate Cancer Data10/26/2026
- 2 Safe S&P 500 Dividend Stocks Boomers Can Buy and Hold Forever10/26/2026
- Johnson & Johnson Prostate Cancer Drug Shrinks Tumors In Early Stage Trial10/26/2026
- Johnson & Johnson Won UK Approval for Its Psoriasis Pill. Here’s Where the Stock Could Go by 203010/26/2026
Prices and news from Yahoo Finance (may be delayed). Company results from SEC filings (available from 2007). Not investment advice.